Showing results (41-50 of 135) with videos related to

Sort By:
Pageof 14
Drug Safety|March 10, 2006
Continuation of amiodarone therapy despite type II amiodarone-induced thyrotoxicosisLaurent Uzan, Laurence Guignat, Christophe Meune, et al.
The Journal of Clinical Endocrinology and Metabolism|May 4, 2006
Clinical and biological features in the prognosis of adrenocortical cancer: poor outcome of cortisol-secreting tumors in a series of 202 consecutive patientsGwenaelle Abiven, Joel Coste, Lionel Groussin, et al.
The Journal of Clinical Endocrinology and Metabolism|August 30, 2008
Midnight salivary cortisol determination for assessing the outcome of transsphenoidal surgery in Cushing's diseaseCarmen A Carrasco, Joël Coste, Laurence Guignat, et al.
The Journal of Clinical Endocrinology and Metabolism|January 12, 2010
Management of Cushing's syndrome due to ectopic adrenocorticotropin secretion with 1,ortho-1, para'-dichloro-diphenyl-dichloro-ethane: findings in 23 patients from a single centerBruno Donadille, Lionel Groussin, Charlotte Waintrop, et al.
The Journal of Clinical Endocrinology and Metabolism|July 24, 2008
Wnt/beta-catenin and 3',5'-cyclic adenosine 5'-monophosphate/protein kinase A signaling pathways alterations and somatic beta-catenin gene mutations in the progression of adrenocortical tumorsSébastien Gaujoux, Frédérique Tissier, Lionel Groussin, et al.
The Journal of Clinical Endocrinology and Metabolism|February 4, 2011
Pregnancy does not accelerate corticotroph tumor progression in Nelson's syndromeFrançois R Jornayvaz, Guillaume Assie, Marie Bienvenu-Perrard, et al.
Molecular Endocrinology (Baltimore, Md.)|August 21, 2004
Synergistic signaling by corticotropin-releasing hormone and leukemia inhibitory factor bridged by phosphorylated 3',5'-cyclic adenosine monophosphate response element binding protein at the Nur response element (NurRE)-signal transducers and activators of transcription (STAT) element of the proopiomelanocortin promoterVanessa Mynard, Olivier Latchoumanin, Laurence Guignat, et al.
International Journal of Endocrinology|February 28, 2015
Value of 18-F-FDG PET/CT and CT in the Diagnosis of Indeterminate Adrenal MassesNathalie Launay, Stéphane Silvera, Florence Tenenbaum, et al.
European Journal of Endocrinology|June 12, 2004
18F-fluorodeoxyglucose positron emission tomography as a diagnostic tool for malignancy of adrenocortical tumours? Preliminary results in 13 consecutive patientsFlorence Tenenbaum, Lionel Groussin, Hervé Foehrenbach, et al.
European Journal of Endocrinology|July 21, 2012
Efficiency and tolerance of mitotane in Cushing's disease in 76 patients from a single centerCamille Baudry, Joël Coste, Roula Bou Khalil, et al.
Pageof 14